| Date Filed | Type | Description |
| 08/21/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 243 shares
@ $1.414, valued at
$343.6 |
|
| 08/09/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 44,650 options to buy
@ $1.62, valued at
$72.3k
|
|
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| Woody Tracy M (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| Fischer Seth H. Z. (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| Shepard Jay (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| ROCAMBOLI STEPHEN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| GOTTO ANTONIO M JR MD D PHIL (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 05/18/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 219 shares
@ $1.624, valued at
$355.7 |
|
| 05/11/2023 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 8,409 shares
@ $1.4919, valued at
$12.5k
Bought 23,091 shares
@ $1.5714, valued at
$36.3k
|
|
| 05/11/2023 |
4
| ROCAMBOLI STEPHEN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 8,111 shares
@ $1.495, valued at
$12.1k
|
|
| 05/10/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.2596, valued at
$25.2k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2023 |
4
| Looker Benjamin (General Counsel) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 20,500 shares
@ $0
Granted 86,900 options to buy
@ $4.02, valued at
$349.3k
|
|
| 03/15/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 22,300 shares
@ $0
Granted 94,500 options to buy
@ $4.02, valued at
$379.9k
|
|
| 03/15/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 105,000 shares
@ $0
Granted 445,000 options to buy
@ $4.02, valued at
$1.8M
|
|
| 03/15/2023 |
4
| Halladay Benjamin (CFO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 9,200 shares
@ $0
Granted 39,000 options to buy
@ $4.02, valued at
$156.8k
|
|
| 03/15/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 28,750 shares
@ $0
Granted 122,500 options to buy
@ $4.02, valued at
$492.5k
|
|
| 03/08/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 5,090 shares
@ $5.055, valued at
$25.7k
|
|
| 03/08/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 5,441 shares
@ $5.056, valued at
$27.5k
|
|
| 03/08/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 3,884 shares
@ $5.065, valued at
$19.7k
|
|
| 01/19/2023 |
4
| Looker Benjamin (General Counsel) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 6,347 shares
@ $6.996, valued at
$44.4k
|
|
| 01/19/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 1,191 shares
@ $6.985, valued at
$8.3k
|
|
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|